Topical numbing cream is usually applied before the procedure to minimise discomfort
Our lives and our livelihood
In the United States alone, the number of patients starting GLP-1 treatments for non-diabetic purposes has increased by 700% since 2019, with estimates suggesting that over 220,000 patients started treatment each month in 2024
If nausea is severe and persistent, discuss with your prescriber
To ensure maximum safety and effectiveness, one must consider the following points before taking treatment: They should be clinically and FDA approved
The panel includes a lipid panel, a comprehensive metabolic panel (CMP), and a hemoglobin A1c (HbA1c) panel: Lipid panel : establishes baseline cholesterol and triglycerides to track cardiovascular-related changes during GLP-1 treatment [4] Comprehensive metabolic panel (CMP) : evaluates 14 biomarkers related to organ function, electrolytes, and metabolic health to get a baseline for monitoring the drugs effectiveness and potential side effects like dehydration [5] Hemoglobin A1c (HbA1c) : measures average blood sugar over 23 months to assess long-term glucose control and guide diabetes-related treatment decisions [6] Together, these tests provide baseline metabolic and cardiovascular information that helps Levity providers safely prescribe and monitor GLP1 medications for weight management